NO

Noctrix Health

Pleasanton, US · 5 known investors

noctrixhealth.com ↗

Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes. The company targets patients living with chronic conditions such as restless legs syndrome, offering prescription-grade therapy through medical devices.

Investors · 5

AN

Angelini VenturesRome

BL

Blue Venture FundsChicago · $1M – $20M

OR

OrbiMedNew York · $1M – $75M

TR

Treo Ventures, LlcMinneapolis

ZÜ

Zühlke VenturesZurich · $165K – $275K